Study of Pattern of Dyslipidaemia among Type 2 Diabetes Mellitus Patients Seeking Care in GMERS Medical College Patan, Gujarat, India
DOI:
https://doi.org/10.37506/ijop.v7i4.80Keywords:
Glycaemic control, HbA1c, Dyslipidemia, Cardiovascular risk.Abstract
Background
Patients with type-2 diabetes have increased risk of myocardial infarction associated with atherogenic dyslipidemia. The diabetic dyslipidemia is characterised by elevations of low density lipoproteins (LDL), triglycerides (TG) and decreased high density lipoproteins (HDL). Lipid particles in diabetic dyslipidemia patients are more atherogenic than in non-diabetic people. Therefore, lipid abnormalities in diabetes should be aggressively treated the at the earlier.
Objective
(a) To study the pattern of dyslipidemia in diabetic patients, and (b) To compare lipid profile among patients with poor glycaemic control and good glycaemic control patients. (c) To access cardiovascular risk status according to criteria of Adult treatment panel III of National Cholesterol Education Program (NCEP).
Material & Method
The present study was carried out at GMERS medical college, Patan Gujarat during period from July 2018 to December 2018. All patient was advised for 12–14 hours overnight fasting and blood samples were collected on next morning before breakfast for lipid profile, FBS, PPBS, HbA1C. Cardiovascular risk status was evaluated according to the criteria of Adult treatment panel III of National Cholesterol Education Program (NCEP).
Results
Out of 150 patients, 46 (30.6%) patients had good glycaemic control and 104 (69.4%) had poor glycaemic control. The patients with poor glycaemic control are at borderline to high cardiovascular risk status as determined by TG and LDL-C levels and serum cholesterol levels.
Conclusion
From the present study we can conclude that diabetic patients with poor glycaemic control are at higher cardiovascular risk according to serum cholesterol, LDL-C levels and TG levels. In addition to glycemic control, HbA1c can be utilized as a potential biomarker to predict dyslipidemia in type 2 diabetic patients
Downloads
Published
Issue
Section
License
Copyright Ownership: Authors retain copyright ownership of their work after publication in IJOP. However, they grant the journal an exclusive Creative Commons license.
Creative Commons License: The authors grant IJOP the right to exclusively apply a Creative Commons license to their work upon publication. This license permits use, distribution, and reproduction of the work in any medium, provided that the original work and its source are properly cited. The specific license applied is Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which allows for attribution, non-commercial use, and derivative works.
Editorial Research: Authors grant the journal the right to analyze information obtained from submitted manuscripts for editorial research purposes. This analysis aims to improve the peer-review process, teaching, and training activities.
Warranties: Authors warrant that their work is original, contains no libelous statements, is lawful, and does not infringe upon any copyright, trademark, patent, or proprietary rights of others. Authors agree to indemnify the editors against any costs, expenses, and damages arising from any breach of this warranty.
Views and Opinions: The views and opinions expressed in the article are those of the authors and not necessarily those of the journal.